144 related articles for article (PubMed ID: 4447377)
1. [Cutaneus vasoconstrictive effect of mineralocorticoids].
Weirich EG; Lutz U
Arch Dermatol Forsch; 1974; 250(4):359-68. PubMed ID: 4447377
[No Abstract] [Full Text] [Related]
2. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. III. Vasoeffect of mineralocorticoids time slope of vasoconstriction influence of steroid concentration].
Altmeyer P; Zaun H
Arch Dermatol Forsch; 1974; 250(4):381-8. PubMed ID: 4447379
[No Abstract] [Full Text] [Related]
3. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
Weirich EG; Lutz U
Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
[No Abstract] [Full Text] [Related]
4. [Comparison of the effectiveness of locally administered corticosteroids].
Semrádová V; Horácek J
Cesk Dermatol; 1974 Jul; 49(4):222-6. PubMed ID: 4844681
[No Abstract] [Full Text] [Related]
5. Vasoconstrictor and systemic activities of topical steroids.
Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
[No Abstract] [Full Text] [Related]
6. [Comparison of the efficiency of various externally used corticosteroids].
Horácek J; Semrádová V
Z Hautkr; 1974 Jul; 49(13):555-8. PubMed ID: 4423320
[No Abstract] [Full Text] [Related]
7. [Remarks on the percutaneous absorption of corticoids].
Rimbaud P; Meynadier J
Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207
[No Abstract] [Full Text] [Related]
8. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
Coldman MF; Lockerbie L; Laws EA
Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
[No Abstract] [Full Text] [Related]
9. Bioassay system for formulations of topically applied glucocorticosteroids.
Stoughton RB
Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
[No Abstract] [Full Text] [Related]
10. Corticosteroid-induced inhibition of the biosynthesis of human skin collagen.
Uitto J; Teir H; Mustakallio KK
Biochem Pharmacol; 1972 Aug; 21(16):2161-7. PubMed ID: 4646188
[No Abstract] [Full Text] [Related]
11. [Corticosteroid effect and vasoconstriction. 1. Suppression of corticosteroid-induced vasoconstriction in the healthy skin by tolazoline].
Brehm K; Maucher OM
Arzneimittelforschung; 1972 Jun; 22(6):1038-9. PubMed ID: 5068352
[No Abstract] [Full Text] [Related]
12. Assay of topical corticosteroids by suppression of experimental inflammation in humans.
Kaidbey KH; Kligman AM
J Invest Dermatol; 1974 Sep; 63(3):292-7. PubMed ID: 4850664
[No Abstract] [Full Text] [Related]
13. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
Poulsen BJ; Burdick K; Bessler S
Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
[No Abstract] [Full Text] [Related]
14. The effect of corticosteroids on human epidermal mitotic activity.
Fisher LB; Maibach HI
Arch Dermatol; 1971 Jan; 103(1):39-44. PubMed ID: 4321801
[No Abstract] [Full Text] [Related]
15. [Effects of tropical application of steroids on the skin].
Tagami H
Hifuka Kiyo; 1971 Feb; 66(1):1-45. PubMed ID: 5170320
[No Abstract] [Full Text] [Related]
16. Various vagaries of vasoconstriction.
Burdick KH
Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376
[No Abstract] [Full Text] [Related]
17. Objective measurement of topically applied corticosteroids.
Király K; Soós G
Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the vasoconstrictor activity of halopredone acetate in a modified McKenzie test.
Rampini E; Rastelli A; Cardo P
Eur J Clin Pharmacol; 1978 Dec; 14(5):325-9. PubMed ID: 729625
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacology of dermatocorticoids (2. Continuation)].
Weirich EG
Z Hautkr; 1978 Apr; 53(7):209-16 contd. PubMed ID: 645170
[No Abstract] [Full Text] [Related]
20. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
Smith EB; Gregory JF; Bartruff JK
South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
